Drugs / ezetimibe/simvastatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00202878 | Oct 2005 → Sep 2014 | hyperlipidemia, myocardial infarction | Organon and Co | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ezetimibe/simvastatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00202878 ↗ |
| Known as | E/S | “40 mg ezetimibe/simvastatin (E/S) or 40 mg placebo/simvastatin.” PMID 29263150 ↗ Dec 2017 |